Repeated dosing of digoxin-fragmented antibody in preterm eclampsia

Journal of Perinatology

Volumn 29, Issue 2, 2009, Pages 163-165

  Adair, C D ^a   Buckalew, V M ^b   Kipikasa, J ^a   Torres, C ^a   Stallings, S P ^a   Briery, C M ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIGOXIN ANTIBODY F(AB) FRAGMENT; MAGNESIUM SULFATE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BREECH PRESENTATION; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; CLONUS; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DOPPLER FLOWMETRY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; ECHOGRAPHY; ECLAMPSIA; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEADACHE; HUMAN; HYPERTENSION; HYPERURICEMIA; INTERVENTION STUDY; LOADING DRUG DOSE; OFF LABEL DRUG USE; OPHTHALMOSCOPY; PERIPHERAL EDEMA; PREGNANCY OUTCOME; PREMATURITY; PRIMIGRAVIDA; PROTEINURIA; SEIZURE; TENDON REFLEX; UREA NITROGEN BLOOD LEVEL; URINALYSIS; VISUAL FIELD DEFECT;

ADOLESCENT; ANTIBODIES; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH;

EID: 59549093000     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.181     Document Type: Article

References (18)

1. Diagnosis and Management of Preeclampsia and Eclampsia. American College of Obstetricians and Gynecologists 2008 Compendium of selected publications: Washington DC, ACOG Practice Bulletin #33, January 2002, pp 717-725.
2. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC, Wenstrom KD. Hypertensive Disorders in Pregnancy, Williams Obstetrics, 22 ed, McGraw-Hill, New York, 2005, pp 761-808.
3. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005; 105: 402-410.
4. NIH Consensus Development Conference Reaffirms Single Course of Antenatal Corticosteroids for Preterm Women. Cites Insufficient Evidence for Repeat Courses. NIH News Release 18 August 2000. http://consensus.nih.gov.
5. Sibai BM, Akl S, Fairlie F, Moretti M. A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 1990; 163: 733-738.
6. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28-32 weeks' gestation: A randomized controlled trial. Am J Obstet Gynecol 1994; 171: 818-822.
7. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: A randomized controlled trial. Obstet Gynecol 1990; 76: 1070-1075.
8. Haddad B, Deis S, Goffinet F, Paniel BJ, Cabrol D, Sibai BM. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol 2004; 190: 1590-1597.
9. Goodlin RC. Antidigoxin antibodies in eclampsia. N Engl J Med 1988; 318: 518-519.
10. Adair CD, Buckalew VM, Taylor K, Ernest JM, Frye AH, Evans C et al Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: Treatment with digoxin-binding immunoglobulin. Am J Nephrol 1996; 16: 529-531.
11. Gilson GJ, Graves SW, Qualls CR, Curet LB. Digoxin-like immunoreactive substance and sodium-potassium-adenosine triphosphatase inhibition in normal pregnancy: A longitudinal study. Obstet Gynecol 1997; 89 743-746.
12. + uptake by erythrocytes in extracts of human plasma. Clin Sci 1989; 77: 375-381.
13. Garzetti GG, Tranquilli AL, Cugini AM, Mazzanti L, Cester N, Romanini C. Altered lipid composition, increased lipid peroxidation, and altered fluidity of the membrane as evidence of platelet damage in preeclampsia. Obstet Gynecol 1993; 81: 337-340.
14. Gusdon JP, Buckalew VM, Hennessy JF. A digoxin-like immunoreactive substance in preeclampsia. Am J Obstet Gynecol 1984; 150: 83-85.
15. Beyer AD, Odendaal HJ, Spruyt LL, Parkin DP. The possible role of endogenous digitalis-like substance in the causation of preeclampsia. SA Mediese Tydskrif 1984; 65: 883-885.
16. Kaminski K, Rechberger T. Concentration of digoxin-like immunoreactive substance in patients with preeclampsia and its relation to severity of pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 165 773-776.
17. Graves SW. Sodium regulation, sodium pump function and sodium pump inhibitors in uncomplicated pregnancy and preeclampsia. Front Biosci 2007; 12: 2438-2446.
18. Poston L. Sodium transport inhibitors in pregnancy-inducted hypertension. Cardiovasc Drugs Ther 1990; 4(Suppl 2): 351-356.